Bone Risks Linked to Genetic Variants
News Sep 29, 2015
Over 10 million people nationwide have osteoporosis, in which bones become susceptible to fracture. Osteoporosis tends to run in families, and genetics is known to play an important role in bone mineral density, a major risk factor for fractures. Scientists have already identified many genetic factors associated with bone mineral density. But these factors likely represent just a small fraction of the underlying genetic variance.
Past efforts to link genetic variants with traits and diseases have largely uncovered common variants with relatively small effects. Recent studies have found less common non-coding variants with larger effects.
An international team of researchers led by Dr. Brent Richards at McGill University set out to examine the role of rare genetic variants in bone mineral density and fracture risk. The scientists used data from the UK10K Project—a massive, whole‐genome sequence‐based resource of the general European population; the NIH-funded 1000 Genomes Project, one of the world’s earliest efforts to sequence the genomes of a large number of people; and data from several other studies.
The team first performed whole‐genome sequencing of more than 2,800 people from the UK10K Project. They also sequenced the exomes (protein-coding regions) of more than 3,500 people. In a sophisticated analysis, the scientists compared these data with those from previous studies involving tens of thousands of other people. They then analyzed associations between the genetic variants and bone mineral density measurements taken in more than 53,000 people. Finally, they looked at data from more than 508,000 people to determine the relationship of the variants to actual bone fractures.
The team identified variants in a region near the engrailed homeobox‐1 gene (EN1) that were associated with bone mineral density in the lumbar area of the spine. One variant was also associated with bone mineral density in the thigh bone at the hip (the “neck” of the femur). Both are common sites of osteoporotic fractures. The effect of these variations, the researchers found, is greater than that of any previously reported genetic variants related to bone density.
Using a mouse model, the team genetically altered En1 levels and confirmed that it plays an important role in bone physiology. Loss of En1results in low bone mass, probably due to high bone turnover.
“EN1 has never before been linked to osteoporosis in humans, so this opens up a brand new pathway to pursue in developing drugs to block the disease,” Richards says.
The researchers also found several other variants associated with bone mineral density in specific areas, including 3 for forearm, 14 for femoral neck, and 19 for lumbar spine. These discoveries indicate that more comprehensive sequencing of diverse populations can lead to the discovery of rare variants influencing common diseases.
“Our findings enhance understanding of the genetics underlying the development of osteoporosis. A variant in a region of the genome that is not coding for a protein can have a relatively large effect on a gene regulating bone health,” says Dr. Douglas Kiel, whose NIH-funded team at Hebrew SeniorLife and Harvard Medical School played a key role in the effort. “Ideally, genomic research will one day lead to more personalized interventions (precision medicine) that, in this case, will reduce bone loss and prevent fractures in older adults.”